• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
RetailHealth

Walgreens accused of filling millions of illegitimate prescriptions, including for opioids

By
The Associated Press
The Associated Press
Down Arrow Button Icon
By
The Associated Press
The Associated Press
Down Arrow Button Icon
January 18, 2025, 10:15 AM ET
Walgreens systematically pressured pharmacists to fill prescriptions without taking the time to confirm their validity, according to the complaint.
Walgreens systematically pressured pharmacists to fill prescriptions without taking the time to confirm their validity, according to the complaint.Gene J. Puskar—AP Photo

The U.S. Justice Department is accusing Walgreens of filling millions of prescriptions in the last decade and more without a legitimate purpose, including for dangerous amounts of opioids, according to a lawsuit filed this week.

Recommended Video

Filed in the U.S. District Court for the Northern District of Illinois, the complaint says the drugstore chain’s pharmacists filled controlled substance prescriptions with clear red flags that indicated they were highly likely to be unlawful. Walgreens also systematically pressured pharmacists to fill prescriptions without taking the time to confirm their validity, according to the complaint.

The lawsuit says Walgreens filled “unlawful” prescriptions in violation of the federal Controlled Substances Act and sought reimbursement from federal health care programs for them in violation of the False Claims Act.

Walgreens, one of the country’s largest pharmacy chains, with over 8,000 locations, said in a statement that it stands behind its pharmacists. It said they say fill legitimate prescriptions for Food and Drug Administration-approved medications written by Drug Enforcement Administration-licensed prescribers in accordance with all applicable laws and regulations.

Walgreens is also accused of ignoring evidence, including from its own pharmacists and internal data, that stores were dispensing unlawful prescriptions, according to the complaint. In addition, it allegedly deprived pharmacists of crucial information including by preventing them from warning each another about particular prescribers.

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division, said in a statement. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

The company said it is asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary “rules” that do not appear in any law or regulation and never went through any official rulemaking process.

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with “rules” that simply do not exist,” Walgreens said in the statement.

The company also said it has been a leader in providing education and resource, as well as implementing the best policies and procedures to help combat opioid misuse.

The DOJ filed a similar lawsuit against CVS in December. A spokesperson for that chain has said it strongly disagrees with the allegations and what it called a “false narrative” in the complaint.

Federal prosecutors have been trying to hold companies accountable for their alleged roles in the U.S. Addiction and overdose crisis, with opioids tied to over 80,000 annual deaths in some recent years.

During the past decade, most of those deaths have mostly been attributed to illicit fentanyl, which is laced into many illegal drugs. Prescription pills were the primary cause earlier.

Over the past eight years, drugmakers, wholesalers and pharmacies have agreed to approximately $50 billion in settlements with governments, with the majority of the money going toward fighting the crisis.

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
By The Associated Press
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.